Cargando…
Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
Positron emission tomography (PET) imaging with radiolabeled drugs holds great promise to assess the influence of membrane transporters on hepatobiliary clearance of drugs. To exploit the full potential of PET, quantitative pharmacokinetic models are required. In this study, we evaluated the suitabi...
Autores principales: | Hernández Lozano, Irene, Karch, Rudolf, Bauer, Martin, Blaickner, Matthias, Matsuda, Akihiro, Wulkersdorfer, Beatrix, Hacker, Marcus, Zeitlinger, Markus, Langer, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488550/ https://www.ncbi.nlm.nih.gov/pubmed/31037511 http://dx.doi.org/10.1208/s12248-019-0323-0 |
Ejemplares similares
-
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
por: Bauer, Martin, et al.
Publicado: (2017) -
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography
por: Wulkersdorfer, Beatrix, et al.
Publicado: (2019) -
Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues
por: Wulkersdorfer, B, et al.
Publicado: (2014) -
A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of (11)C- and (14)C-labelled verapamil in healthy volunteers
por: Wagner, Claudia C, et al.
Publicado: (2008) -
Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)